Risk of Stroke in Patients with Rheumatism: A Nationwide Longitudinal Population-based Study

被引:46
作者
Liou, Tsan-Hon [1 ,2 ]
Huang, Shih-Wei [1 ]
Lin, Jia-Wei [3 ,4 ]
Chang, Yu-Sheng [5 ]
Wu, Chin-Wen [1 ]
Lin, Hui-Wen [6 ,7 ]
机构
[1] Taipei Med Univ, Shuang Ho Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan
[2] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan
[3] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, Taipei, Taiwan
[4] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan
[5] Taipei Med Univ, Shuang Ho Hosp, Dept Rheumatol, Taipei, Taiwan
[6] Soochow Univ, Dept Math, Taipei, Taiwan
[7] Taipei Med Univ, Wan Fang Hosp, Evidence Based Med Ctr, Taipei, Taiwan
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; ISCHEMIC-STROKE; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; DISEASE; COHORT; ATHEROSCLEROSIS; ARTHRITIS; HOSPITALIZATION; POLYMORPHISMS;
D O I
10.1038/srep05110
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The aim of this study was to investigate rheumatoid arthritis (RA), and systemic lupus erythematous (SLE) as risk factors for stroke. The study was analyzed by Using the Taiwan Longitudinal Health Insurance Database 2005 (LHID2005), this cohort study investigated patients with a recorded diagnosis of RA (N = 6114), and SLE (N = 621) between January 1, 2004, and December 31, 2007, with age-matched controls (1:4) (for RA, N = 24456; SLE, N = 2484). We used Cox proportional-hazard regressions to evaluate the hazard ratios (HRs) after adjusting confounding factors. Our study found 383 of 6114 RA patients, experienced stroke during the 20267 person-year follow-up period. The adjusted HR of stroke for RA patients was 1.24 (95% CI, 1.11 to 1.39), and for SLE patients was 1.88 (95% CI, 1.08 to 3.27). When steroid was added as additional confounding factor, the adjusted HR of ischemic stroke for RA patients was 1.32 (95% CI, 1.15 to 1.50), and for SLE patients was 1.31 (95% CI, 0.51 to 3.34). In conclusion, the rheumatic diseases of RA, and SLE are all risk factors for stroke. After controlled the effect of steroid prescription, RA is risk factor for ischemic stroke.
引用
收藏
页数:6
相关论文
共 44 条
[31]   CORONARY-ARTERY DISEASE RISK-FACTORS IN THE JOHNS-HOPKINS LUPUS-COHORT - PREVALENCE, RECOGNITION BY PATIENTS, AND PREVENTIVE PRACTICES [J].
PETRI, M ;
SPENCE, D ;
BONE, LR ;
HOCHBERG, MC .
MEDICINE, 1992, 71 (05) :291-302
[32]   Microfabricated In-Channel Structured Polydimethylsiloxane Microfluidic System for a Lab-on-a-Chip [J].
Ra, Gyu-Sik ;
Yoo, Jong-Chul ;
Kang, C. J. ;
Kim, Yong-Sang .
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2008, 8 (09) :4588-4592
[33]   Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study [J].
Semb, A. G. ;
Kvien, T. K. ;
Aastveit, A. H. ;
Jungner, I. ;
Pedersen, T. R. ;
Walldius, G. ;
Holme, I. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (11) :1996-2001
[34]   Mechanisms of disease: atherosclerosis in autoimmune diseases [J].
Sherer, Y ;
Shoenfeld, Y .
NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (02) :99-106
[35]  
Södergren A, 2009, CLIN EXP RHEUMATOL, V27, P641
[36]   Patterns of cardiovascular risk in rheumatoid arthritis [J].
Solomon, D. H. ;
Goodson, N. J. ;
Katz, J. N. ;
Weinblatt, M. E. ;
Avorn, J. ;
Setoguchi, S. ;
Canning, C. ;
Schneeweiss, S. .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (12) :1608-1612
[37]   Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis [J].
Solomon, Daniel H. ;
Avorn, Jerry ;
Katz, Jeffrey N. ;
Weinblatt, Michael E. ;
Setoguchi, Soko ;
Levin, Raisa ;
Schneeweiss, Sebastian .
ARTHRITIS AND RHEUMATISM, 2006, 54 (12) :3790-3798
[38]   Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE [J].
Symmons, Deborah P. M. ;
Gabriel, Sherine E. .
NATURE REVIEWS RHEUMATOLOGY, 2011, 7 (07) :399-408
[39]   Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA).: XXX:: association between C-reactive protein (CRP) gene polymorphisms and vascular events [J].
Szalai, AJ ;
Alarcón, GS ;
Calvo-Alén, J ;
Toloza, SMA ;
McCrory, MA ;
Edberg, JC ;
McGwin, G ;
Bastian, HM ;
Fessler, BJ ;
Vilá, LM ;
Kimberly, RP ;
Reveille, JD .
RHEUMATOLOGY, 2005, 44 (07) :864-868
[40]   Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus [J].
Tarr, T. ;
Lakos, G. ;
Bhattoa, H. P. ;
Szegedi, G. ;
Shoenfeld, Y. ;
Kiss, E. .
LUPUS, 2007, 16 (05) :324-328